Anticoccidial vaccine development: the importance of genetic diversity and delivery strategy
Lead Research Organisation:
THE PIRBRIGHT INSTITUTE
Department Name: UNLISTED
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Technical Summary
Coccidiosis is a devastating disease of poultry and other livestock caused by protozoan parasites of the genus Eimeria. Cost-effective, multi-valent recombinant vaccines are a realistic prospect following the identification of immunoprotective parasite antigens and development of parasite transfection technologies. To predict the likely efficacy and longevity of such vaccines in the field it is important to know the prevalence of naturally-occurring genetic (antigenic) diversity, rate of multiple infections, and frequency of genetic exchange between parasites. It is crucial also to have strong geographical networks in place, both for collecting parasites for the laboratory studies outlined above and to ensure efficient dissemination, delivery and support of traditional and new therapeutics (drugs and vaccines) to the world's poorest rural economies.
Planned Impact
unavailable
Organisations
People |
ORCID iD |
| Fiona Tomley (Principal Investigator) |